Bio-Rad updates share repurchase activity: $125M repurchased QTD

BIO-RAD LABORATORIES, INC.

Quarter-to-date through May 17, 2022, Bio-Rad repurchased $125M of Class A common stock.
Repurchased 255k shares at an average price of $489.65 per share.
Total repurchased under program: $351.9M; remaining authorization: $98.1M.
Buyback program authorized Nov 2017 for $250M, increased by $200M in July 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.